+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Antimicrobial Susceptibility Testing - Global Strategic Business Report

  • PDF Icon

    Report

  • 382 Pages
  • February 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4805105

Global Antimicrobial Susceptibility Testing Market to Reach $4.6 Billion by 2030

The global market for Antimicrobial Susceptibility Testing estimated at US$3.5 Billion in the year 2022, is projected to reach a revised size of US$4.6 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2022-2030. Manual Products, one of the segments analyzed in the report, is projected to record a 3.8% CAGR and reach US$1.5 Billion by the end of the analysis period. Growth in the Automated Laboratory Instruments segment is estimated at 3.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $941.4 Million, While China is Forecast to Grow at 6.9% CAGR

The Antimicrobial Susceptibility Testing market in the U.S. is estimated at US$941.4 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$992.2 Million by the year 2030 trailing a CAGR of 6.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.2% and 2.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$642.6 Million by the year 2030.

Select Competitors (Total 52 Featured) -

  • Accelerate Diagnostics, Inc.
  • Alifax S.r.l.
  • Becton Dickinson, and Company
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Biotron Limited
  • Bruker Corp.
  • Creative Diagnostics
  • Danaher Corporation
  • ELITech Group
  • F. Hoffmann-La Roche AG
  • HiMedia Laboratories Pvt. Ltd.
  • Liofilchem S.r.l.
  • Mast Group Ltd.
  • Merck KGaA
  • MP Biomedicals LLC
  • Q-linea AB
  • QuantaMatrix, Inc.
  • Resistell AG
  • Thermo Fisher Scientific, Inc.

What`s New?

  • Special discussions on the global economic climate and market sentiment
  • Coverage on global competitiveness and key competitor percentage market shares
  • Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and research platform
  • Complimentary updates for one year
  • Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes

Economic Outlook

The global economic outlook is improving, and growth recovery, albeit on the lower side, is expected for this year and the next. The United States although witnessing slowing GDP growth in response to tight monetary and financial conditions, has nevertheless overcome the recession threat. Easing of headline inflation in Euro area is helping boost real incomes and is contributing to pick-up in economic activity. China is expected to see strong increases in GDP in the coming year as the pandemic threat recedes and the government sheds its zero-COVID policy. With optimistic GDP projections, India remains on-course to emerge into a US trillion economy by 2030, surpassing Japan and Germany.

The upturn, however, remains fragile and a number of interlocking challenges continue to run in parallel, such as continued uncertainty around the war in Ukraine; slower than expected decline in global headline inflation; continuation of food and fuel inflation as a persistent economic problem for most developing countries; and still high retail inflation and its impact on consumer confidence and spending. Countries and their governments are showing signs of weathering these challenges, which helps lift market sentiments. As governments continue to combat inflation to get it down to more economically conformable levels by raising interest rates, new job creation will slowdown and impact economic activity. Stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced.

Although corporate investments can likely be held back by inflation worries and weaker demand, rise of new technologies will reverse partially this prevailing investment sentiment. Rise of generative AI; applied AI; industrializing machine learning; next-generation software development; Web3; cloud and edge computing; quantum technologies; electrification and renewables and climate technologies beyond electrification and renewables, will open up the global investment landscape. The technologies hold the potential to drive sizeable incremental growth and value to global GDP in the coming years. The short-term is expected to be a mixed bag of challenges and opportunities for both consumers and investors alike. There is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Frequently Asked Questions about the Antimicrobial Susceptibility Testing Market

What is the estimated value of the Antimicrobial Susceptibility Testing Market?

The Antimicrobial Susceptibility Testing Market was estimated to be valued at $3.5 Billion in 2022.

What is the growth rate of the Antimicrobial Susceptibility Testing Market?

The growth rate of the Antimicrobial Susceptibility Testing Market is 3.5%, with an estimated value of $4.6 Billion by 2030.

What is the forecasted size of the Antimicrobial Susceptibility Testing Market?

The Antimicrobial Susceptibility Testing Market is estimated to be worth $4.6 Billion by 2030.

Who are the key companies in the Antimicrobial Susceptibility Testing Market?

Key companies in the Antimicrobial Susceptibility Testing Market include Accelerate Diagnostics, Inc., Alifax S.r.l., Becton Dickinson, and Company, bioMérieux SA, Bio, Rad Laboratories, Inc., Biotron Limited, Bruker Corp., Creative Diagnostics and Danaher Corporation.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • COVID-19 Pandemic Impact and the Global Economic Update
  • War & Inflation Supersede COVID-19 as Major Downside Risks for the Global Economy in 2023 & Beyond
  • Here’s How Inflationary Pressures Affect the Economy
  • Russia-Ukraine War, the Primary Culprit Responsible for the Hardships
  • Stubbornly High Inflation to Single Handedly Drag Down Global Growth
  • Here’s What’s Causing the Current Spike in Inflation
  • Shaken by the War, Global Oil Prices Spiral and Feed Inflationary Pressures, Guiding the World towards a Cost of Living Crisis: Global Average Annual Brent Crude Oil Price (In US$ Per Barrel) for Years 2017 through 2023
  • War-Induced Commodity Price Increases & Broad Based Price Pressures Mark the Return of Global Inflation in 2022 to the Highest Level Seen Since 1996: Global Inflation Rates (In %) for the Years 2019 Through 2024
  • War, Global Inflation, Cost of Living Crisis, Failed Fiscal Policy Attempts to Restore Price Stability & Contain Downside Risks to Result in Sharper-Than-Expected Slowdown in Global Economic Growth: World Economic Growth Projections (Real GDP, Annual % Change) for the Years 2020, 2021, 2022 and 2023
  • Recession Triggered by Uncontrolled Inflation or Unemployment, Which is the Greater Evil? Inflation Battling Policy Measures to Slowdown Post Pandemic Recovery in Unemployment Rates: Global Number of Unemployed People (In Million) for Years 2019 Through 2023
  • Pandemic Impact on Antimicrobial Susceptibility Testing Market
  • An Introduction to Antimicrobial Susceptibility Testing
  • Antibiotic Sensitivity Testing Methods
  • Global Market Prospects & Outlook
  • Segment Analysis
  • Developed Regions Lead, Promising Growth in Store Across Developing Economies
  • Competition
  • Antimicrobial Susceptibility Testing - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Infectious Diseases & Overuse of Antibiotics Fuel Demand for Antimicrobial Susceptibility Testing
  • Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
  • Infectious Diseases Related Mortality High Among Children Below 5 Years: Breakdown of Leading Causes of Death in Children Below 5 Years (in %)
  • Rise in Prevalence of Respiratory Infections Drive Market Growth
  • Global Number of Deaths Caused Due to Communicable Diseases (In 000s)
  • Antimicrobial Susceptibility Testing Finds Growing Acceptance in Clinical Diagnostics
  • Growing Use of Antimicrobial Susceptibility Testing by Biopharma Companies Boosts Market Prospects
  • Pharmaceutical R&D Spending Worldwide (US$ Billion): 2015-2022
  • Increasing Need to Reduce Hospital Acquired Infections Presents Growth Opportunities
  • Leading Nosocomial Infections in the US: Percentage Breakdown of Healthcare Cost by Infection Type
  • Government Initiatives for the Detection & Control of Antimicrobial Resistant Species Augurs Well for the Market
  • AST to Play a Critical Part in Regulating Development of Antimicrobial Resistances
  • Introduction of Digital Technologies Streamlines Process Associated with Developing Vaccines
  • AST Technologies Helping Accelerate Targeted Antimicrobial Therapy
  • Antimicrobial Susceptibility Testing Plays Key Role in Medical Decision Making
  • rAST: Accelerating the Process of Antimicrobial Susceptibility Testing
  • Faster Antibiotic Susceptibility Tests Become Vital for High-Priority Pathogens
  • Digital Technologies Help in Rapid Antimicrobial Susceptibility Testing
  • Emerging AST Methods to Facilitate Wider Adoption
  • Rapidly Evolving Bacterial Pathogens and the Role of Rapid POC AST Diagnostics
  • Demand for Digital Medical Devices Bodes Well for the Market
  • Development of AST Standards to Enable Responsible Antimicrobials Usage
  • Antimicrobial Susceptibility Test Breakpoints
  • Advent of Innovative Technologies Foster Growth for Antimicrobial Susceptibility Testing Market
  • Use of Artificial Intelligence-Based Applications Exhibits a Surge
  • Novel Tools Focus on Antibiotic-Resistant Microbes
  • Researchers Develop Novel Methods to Acquire Outcomes on Susceptibility of Bacteria
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Antimicrobial Susceptibility Testing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Antimicrobial Susceptibility Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 3: World Historic Review for Antimicrobial Susceptibility Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 4: World 16-Year Perspective for Antimicrobial Susceptibility Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Manual Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 6: World Historic Review for Manual Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 7: World 16-Year Perspective for Manual Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Automated Laboratory Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 9: World Historic Review for Automated Laboratory Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 10: World 16-Year Perspective for Automated Laboratory Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Culture & Growth Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 12: World Historic Review for Culture & Growth Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 13: World 16-Year Perspective for Culture & Growth Media by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 15: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 16: World 16-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Antibacterial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 18: World Historic Review for Antibacterial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 19: World 16-Year Perspective for Antibacterial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Antifungal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 21: World Historic Review for Antifungal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 22: World 16-Year Perspective for Antifungal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for Antiparasitic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 24: World Historic Review for Antiparasitic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 25: World 16-Year Perspective for Antiparasitic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 26: World Recent Past, Current & Future Analysis for Other Testing Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 27: World Historic Review for Other Testing Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 28: World 16-Year Perspective for Other Testing Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Antimicrobial Susceptibility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
CANADA
JAPAN
  • Antimicrobial Susceptibility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
CHINA
  • Antimicrobial Susceptibility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
EUROPE
  • Antimicrobial Susceptibility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
FRANCE
  • Antimicrobial Susceptibility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
GERMANY
  • Antimicrobial Susceptibility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
ITALY
UNITED KINGDOM
  • Antimicrobial Susceptibility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Antimicrobial Susceptibility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
AUSTRALIA
  • Antimicrobial Susceptibility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
INDIA
  • Antimicrobial Susceptibility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Antimicrobial Susceptibility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Antimicrobial Susceptibility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Antimicrobial Susceptibility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Accelerate Diagnostics, Inc.
  • Alifax S.r.l.
  • Becton Dickinson, and Company
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Biotron Limited
  • Bruker Corp.
  • Creative Diagnostics
  • Danaher Corporation
  • ELITech Group
  • F. Hoffmann-La Roche AG
  • HiMedia Laboratories Pvt. Ltd.
  • Liofilchem S.r.l.
  • Mast Group Ltd.
  • Merck KGaA
  • MP Biomedicals LLC
  • Q-linea AB
  • QuantaMatrix, Inc.
  • Resistell AG
  • Thermo Fisher Scientific, Inc.